direkt zum Inhalt springen



13.06.2024, 17:00-13.06.2024, 19:00

Talk im Cube: Building the bridge from preclinical to clinical studies

The transition from preclinical studies to human clinical trials is challenging in many ways – scientifically, regulatory and organizationally. Companies need to become even more efficient to get their drugs through the development process.

Panel Discussion:
Building the bridge from preclinical to clinical studies
Proven experts in the field of preclinical and clinical development will introduce into the complexity of the topic and will discuss how to streamline the processes and to minimize risks and pitfalls.


Jens Hoffmann, Managing Director of Experimental Pharmacology & Oncology (EPO), Berlin-Buch GmbH,
Michael Firgens, Managing Director at MF Biotech, Berlin,
Virgilio Garcia Lerma, Executive Director, Regulatory Strategy at Worldwide Clinical Trials, Madrid, Spain,
Uwe Lohmeier, Head of Gläsernes Labor Akademie (GLA), Campus Berlin-Buch GmbH (Moderation)

Key Topics:

• Reflect clinical problems in preclinical models,
• Balance in vitro, animal and human experimentation from an ethical point of view,
• Comply with regulatory requirements such as ICH, EMA, FDA etc.,
• Remain financially successful.

Don’t miss the opportunity to join in the discussion and exchange ideas with each other and our experts over snacks and drinks at the subsequent get-together and networking


BerlinBioCube, Campus Berlin-Buch, Robert-Rössle-Str. 10, 13125 Berlin

Registration is requested.

Alle Termine

Kalender Icon


Alle Termine
Kalender Icon

10.09.2024, 09:00 bis
13.09.2024, 18:00
From Target to Market - The GLA Biotech & Pharma Summer School

Kalender Icon

12.09.2024, 09:00 bis
13.09.2024, 17:00
realtime PCR und digital PCR Kurs

Kalender Icon

08.10.2024, 09:00 bis
17.10.2024, 18:00
GMP Biotech Summer School